SCHEMBL2300477

SCHEMBL2300477

Cc1ccc(CC=C[C]=O)cc1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AGXT P21549 2/20 0.39
IDO1 P14902 3/20 0.38
CYP2A6 P11509 2/20 0.35
CYP1A2 P05177 1/20 0.35
TAAR1 Q96RJ0 1/20 0.35
MAOB P27338 1/20 0.34
TLR9 Q9NR96 1/20 0.34
TP53 P04637 1/20 0.34
MAPT P10636 1/20 0.34
ACHE P22303 2/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA9 Q16790 1/20 0.33
FFAR1 O14842 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CNR2 P34972 1/20 0.33
BCHE P06276 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11400752 0.79 MAOB (0.52) AGXTIDO1CYP2A6CYP1A2TAAR1
SCHEMBL161348 0.79 ALDH1A1 (0.53) AGXTIDO1CYP2A6TAAR1TP53
SCHEMBL261253 0.78 MAOB (0.61) IDO1MAOBTP53CA1CA2
SCHEMBL334261 0.78 MAOB (0.61) IDO1MAOBTP53CA1CA2
SCHEMBL145088 0.78 MAOB (0.61) IDO1MAOBTP53CA1CA2
SCHEMBL19439522 0.76 THRB (0.46) TP53ACHECA2LMNA
SCHEMBL7569322 0.74 IDO1 (0.41) AGXTIDO1CYP2A6CYP1A2TAAR1
SCHEMBL10635864 0.73 AGXT (0.50) AGXTIDO1CYP2A6CYP1A2TAAR1
SCHEMBL2132369 0.73 AGXT (0.50) AGXTIDO1CYP2A6CYP1A2TAAR1
SCHEMBL30753808 0.72 AGXT (0.40) AGXTIDO1CYP2A6CYP1A2TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2536698-A1 ISOXAZOLINE DERIVATIVES AS INSECTICIDES Syngenta Participations AG (CH) 2012-12-26 EP disclosed
WO-2011101402-A1 ISOXAZOLINE DERIVATIVES AS INSECTICIDES SYNGENTA PARTICIPATIONS AG (CH) 2011-08-25 WO disclosed